MiMedx Group, Inc - stock earnings

MDXG Upcoming estimated earnings

Date Actual / Estimated EPS Low Revenue Actual / Estimated Revenue High Revenue
April 30, 2024 AfterMarket 0.07 / 0.05 - 84.7 million / 80.9 million -

MDXG Quarterly earnings

DateEarningsRevenue
2024Q1 9.1 million USD 84.7 million USD
2023Q4 62.7 million USD 86.8 million USD
2023Q3 6.8 million USD 81.7 million USD
2023Q2 1.2 million USD 81.3 million USD
2023Q1 -5.0 million USD 71.7 million USD
2022Q4 -415000 USD 74.4 million USD
2022Q3 -8.4 million USD 67.7 million USD
2022Q2 -10.9 million USD 66.9 million USD
2022Q1 -10.5 million USD 58.9 million USD
2021Q4 2.2 million USD 67.4 million USD
2021Q3 -2.3 million USD 63.1 million USD
2021Q2 -1.8 million USD 68.2 million USD
2021Q1 -8.4 million USD 60.0 million USD
2020Q4 -16.6 million USD 68.5 million USD
2020Q3 -19.4 million USD 64.3 million USD
2020Q2 -13.3 million USD 66.6 million USD
2020Q1 -6.7 million USD 125.5 million USD
2019Q4 -36.2 million USD 92.6 million USD
2019Q3 12.4 million USD 88.9 million USD
2019Q2 -17.2 million USD 67.4 million USD
2019Q1 -13.3 million USD 66.6 million USD
2018Q4 -6.7 million USD 125.5 million USD
2018Q3 -178000 USD 87.0 million USD
2018Q2 1.8 million USD 95.4 million USD
2018Q1 4.6 million USD 84.1 million USD
2017Q4 34.9 million USD 87.5 million USD
2017Q3 17.5 million USD 84.6 million USD
2017Q2 8.1 million USD 76.4 million USD
2017Q1 4.3 million USD 72.6 million USD
2016Q4 5.5 million USD 69.9 million USD
2016Q3 3.3 million USD 64.4 million USD
2016Q2 2.0 million USD 57.3 million USD
2016Q1 1.2 million USD 53.4 million USD
2015Q4 13.4 million USD 51.8 million USD
2015Q3 6.6 million USD 49.0 million USD
2015Q2 5.4 million USD 45.7 million USD
2015Q1 4.1 million USD 40.8 million USD
2014Q4 3.8 million USD 39.6 million USD
2014Q3 3.7 million USD 33.5 million USD
2014Q2 -390159 USD 25.6 million USD
2014Q1 -922072 USD 19.6 million USD
2013Q4 -1.4 million USD 18.0 million USD
2013Q3 -307118 USD 16.1 million USD
2013Q2 -757389 USD 13.5 million USD
2013Q1 -1.6 million USD 11.6 million USD
2012Q4 -1.6 million USD 10.5 million USD
2012Q3 -4.2 million USD 8.0 million USD
2012Q2 -744069 USD 4.9 million USD
2012Q1 -1.1 million USD 3.7 million USD
2011Q4 -2.6 million USD 2.6 million USD
2011Q3 -1.8 million USD 2.2 million USD
2011Q2 -2.5 million USD 1.9 million USD
2011Q1 -3.3 million USD 1.0 million USD
2010Q4 -2.7 million USD 243918 USD
2010Q3 -2.9 million USD 108027 USD
2010Q2 -2.7 million USD 322075 USD
2010Q1 -3.1 million USD 114855 USD
2009Q4 -2.2 million USD ? USD
2009Q3 -4.5 million USD ? USD
2009Q2 -1.6 million USD ? USD
2009Q1 -2.9 million USD ? USD
2008Q4 -2.3 million USD ? USD
2008Q3 -3.6 million USD ? USD
2008Q2 -3.2 million USD 158260 USD
2008Q1 -17.4 billion USD ? USD
2007Q4 -8082 USD ? USD
2007Q3 -5646 USD ? USD
2007Q2 -8975 USD ? USD
2007Q1 -16159 USD ? USD

MDXG Yearly earnings

DateEarningsRevenue
2023 67.4 million USD 321.5 million USD
2022 -30.2 million USD 267.8 million USD
2021 -10.3 million USD 258.6 million USD
2020 -49.3 million USD 248.2 million USD
2019 -30.0 million USD 359.1 million USD
2018 -30.0 million USD 359.1 million USD
2017 64.7 million USD 321.1 million USD
2016 12.0 million USD 245.0 million USD
2015 29.4 million USD 187.3 million USD
2014 6.2 million USD 118.2 million USD
2013 -4.1 million USD 59.2 million USD
2012 -7.7 million USD 27.1 million USD
2011 -10.2 million USD 7.8 million USD
2010 -11.4 million USD 788874 USD
2009 -8.3 million USD ? USD
2008 -11.9 million USD ? USD
2007 -38860 USD ? USD
2006 -16738 USD ? USD

MDXG

Price: $7.13

52 week price:
3.14
9.27

Earnings Per Share: 0.43 USD

P/E Ratio: -389

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 527584

Ebitda: 10.3 million

Market Capitalization: 1.1 billion

Links: